Hired & Retired: From big pharma to mid-sized leadership 24-Jun-2020 By Ben Hargreaves This month featured executives making the switch from big pharma to take on leadership positions at mid-sized companies.
WuXi AppTec launches closed process CAR-T platform 25-May-2020 By Ben Hargreaves The cell therapy platform will provide development, manufacturing and release services to companies working on CAR-T therapies.
CANbridge backed by $98m in Series D financing 20-Feb-2020 By Ben Hargreaves The Chinese biotech gained support from global investors, with leading investors being General Atlantic and WuXi AppTec.
ABL extends antibody agreement in $220m deal with WuXi Biologics 27-Feb-2019 By Maggie Lynch ABL will use WuXi’s platforms in an extended agreement for the development and commercialization of its bispecific antibodies, using the recently launched WuXiBody platform.
